---
title: "Runx1–Gata2 Axis in Hematopoiesis: Epigenetic Control of Lineage Fate"
id: "pubmed-42801378"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42801378"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42801378/"
doi: "10.1007/s11033-026-12742-6"
published_at: "2026-09-27T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Runx1–Gata2 Axis in Hematopoiesis: Epigenetic Control of Lineage Fate
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42801378
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42801378/)
- **DOI:** [10.1007/s11033-026-12742-6](https://doi.org/10.1007%2Fs11033-026-12742-6)
- **Published At:** 2026-09-27T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The review synthesizes recent evidence that the **Runx1–Gata2** transcriptional axis is central to establishing cellular identity during hematopoiesis by coordinating transcription factor activity with chromatin remodeling complexes. - **Gata2** is described as a pioneer transcription factor able to access closed chromatin and initiate regulatory programs that support hematopoietic stem and progenitor cell states. - **Runx1** contributes to higher-order chromatin organization by reshaping topologically associating domains (TADs) and facilitating enhancer–promoter interactions critical for lineage specification and self-renewal. - Runx1 recruits chromatin effectors including chromodomain helicase DNA-binding protein 7 (**CHD7**) and ten-eleven translocation enzymes (**TET**), linking transcription factor binding to DNA and chromatin modification pathways. - Perturbations of the axis—such as hypermethylation, enhancer hijacking, or haploinsufficiency—create an **epigenetic addiction** that promotes myeloid malignancies, notably acute myeloid leukemia (**AML**) and myelodysplastic syndromes (**MDS**). - The authors review emerging therapeutic avenues aimed at restoring chromatin architecture in malignant clones, including **epigenetic editing** and **super-enhancer targeting**, as strategies to reverse pathogenic regulatory states. - The review emphasizes roles for Runx1 and Gata2 beyond classical chromatin architecture functions and consolidates mechanistic links between transcription factor activity, chromatin topology, and disease pathogenesis. - The article is a review published in Molecular Biology Reports (2026) by Sumit Mallick and Anirban Chakraborty and lists AML, epigenetics, Gata2, hematopoietic stem cells, pathogenesis, and Runx1 among its keywords.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42801378/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42801378%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42801378/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42801378/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42801378/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/8267210f-05e7-427e-8182-362dc216972f/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42801378/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42801378/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42801378%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42801378%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42801378/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42801378/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42801378/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42801378/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42801378/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42801378/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42801378/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42801378/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42801378/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42801378/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42801378/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42801378/#substances) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Substances Review Mol Biol Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mol+Biol+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Mol+Biol+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) . 2026 Sep 27;53(1):1643. doi: 10.1007/s11033-026-12742-6. # The Runx1-Gata2 axis: epigenetic architecture of lineage fate [Sumit Mallick](https://pubmed.ncbi.nlm.nih.gov/?term=Mallick+S&cauthor_id=42801378)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#full-view-affiliation-1 "Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte \(Deemed to Be University\), Mangalore, India.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#full-view-affiliation-2 "Cellular Biophysics Lab, Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay, Powai, Maharashtra, 400076, India."), [Anirban Chakraborty](https://pubmed.ncbi.nlm.nih.gov/?term=Chakraborty+A&cauthor_id=42801378)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#full-view-affiliation-3 "Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte \(Deemed to Be University\), Mangalore, India. anirban.nitte@edu.in.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#full-view-affiliation-4 "Department of Medical Oncology, KS Hegde Medical Academy, Nitte \(Deemed to Be University\), Mangalore, India. anirban.nitte@edu.in.") Affiliations Expand ### Affiliations * 1 Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to Be University), Mangalore, India. * 2 Cellular Biophysics Lab, Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay, Powai, Maharashtra, 400076, India. * 3 Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to Be University), Mangalore, India. anirban.nitte@edu.in. * 4 Department of Medical Oncology, KS Hegde Medical Academy, Nitte (Deemed to Be University), Mangalore, India. anirban.nitte@edu.in. * PMID: **42801378** * DOI: [ 10.1007/s11033-026-12742-6 ](https://doi.org/10.1007/s11033-026-12742-6) Item in Clipboard Review # The Runx1-Gata2 axis: epigenetic architecture of lineage fate Sumit Mallick et al. Mol Biol Rep. 2026. Show details Display options Display options Format Abstract PubMed PMID Mol Biol Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mol+Biol+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Mol+Biol+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) . 2026 Sep 27;53(1):1643. doi: 10.1007/s11033-026-12742-6. ### Authors [Sumit Mallick](https://pubmed.ncbi.nlm.nih.gov/?term=Mallick+S&cauthor_id=42801378)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#short-view-affiliation-1 "Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte \(Deemed to Be University\), Mangalore, India.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#short-view-affiliation-2 "Cellular Biophysics Lab, Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay, Powai, Maharashtra, 400076, India."), [Anirban Chakraborty](https://pubmed.ncbi.nlm.nih.gov/?term=Chakraborty+A&cauthor_id=42801378)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#short-view-affiliation-3 "Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte \(Deemed to Be University\), Mangalore, India. anirban.nitte@edu.in.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42801378/#short-view-affiliation-4 "Department of Medical Oncology, KS Hegde Medical Academy, Nitte \(Deemed to Be University\), Mangalore, India. anirban.nitte@edu.in.") ### Affiliations * 1 Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to Be University), Mangalore, India. * 2 Cellular Biophysics Lab, Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay, Powai, Maharashtra, 400076, India. * 3 Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to Be University), Mangalore, India. anirban.nitte@edu.in. * 4 Department of Medical Oncology, KS Hegde Medical Academy, Nitte (Deemed to Be University), Mangalore, India. anirban.nitte@edu.in. * PMID: **42801378** * DOI: [ 10.1007/s11033-026-12742-6 ](https://doi.org/10.1007/s11033-026-12742-6) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Cellular identity is established through the precise coordination of transcription factors (TFs) and chromatin remodeling complexes that shape the epigenetic landscape. In hematopoiesis, the interaction between Runx1 and Gata2 transcription factors exemplifies the role of master TFs in direct lineage specification and self-renewal. In this review, we have consolidated recent findings on the epigenetic regulation of the master TFs of the Runx1-Gata2 axis, highlighting roles beyond their classical functions as chromatin architects. Gata2 functions as a pioneer factor that accesses closed chromatin, while Runx1 participates in reshaping topologically associating domains (TADs) and enhancer-promoter interactions, recruiting effectors such as chromodomain helicase DNA-binding protein 7 (CHD7) and ten-eleven translocation (TET) enzymes. Disruptions to this axis, including hypermethylation, enhancer hijacking, or haploinsufficiency, lead to an "epigenetic addiction" in myeloid malignancies, promoting the development of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). We have discussed the recent research on emerging therapeutic strategies, such as epigenetic editing and super-enhancer targeting, which aim to restore proper chromatin architecture in malignant clones. **Keywords:** AML; Epigenetics; Gata2; Hematopoietic Stem Cells; Pathogenesis; Runx1. © 2026. The Author(s), under exclusive licence to Springer Nature B.V. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Competing Interests: We declare no conflict of interest. Use of artificial intelligence and AI-assisted technologies: During the preparation of this work the authors used a generative AI tool solely to improve the language, grammar and readability of the text. After using this tool the authors reviewed and edited the content as required and take full responsibility for the content of the published article. ## References 1. 1. Wilson NK et al (2010) Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7(4):532–544. - [DOI](https://doi.org/10.1016/j.stem.2010.07.016) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/20887958/) 2. 1. Pei W et al (2017) Polylox barcoding reveals haematopoietic stem cell fates realized in vivo. Nature 548(7668):456–460. - [DOI](https://doi.org/10.1038/nature23653) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/28813413/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/5905670/) 3. 1. Mallick S. (2026). DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates thehaematopoiesis. Molecular biology reports, 53(1), 1107 - [DOI](https://doi.org/10.1007/s11033-026-12293-w) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/42083305/) 4. 1. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA (2009) Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457(7231):887–891. - [DOI](https://doi.org/10.1038/nature07619) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/19129762/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/2744041/) 5. 1. de Bruijn M, Dzierzak E (2017) Runx transcription factors in the development and function of the definitive hematopoietic system. Blood 129(15):2061–2069. - [DOI](https://doi.org/10.1182/blood-2016-12-689109) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/28179276/) Show all 76 references ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Cell Lineage / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Lineage%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Lineage) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Chromatin / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chromatin%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Chromatin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Chromatin / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chromatin%2Fmetabolism%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Chromatin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Chromatin Assembly and Disassembly Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chromatin+Assembly+and+Disassembly%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Chromatin+Assembly+and+Disassembly) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Core Binding Factor Alpha 2 Subunit* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Core+Binding+Factor+Alpha+2+Subunit%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Core+Binding+Factor+Alpha+2+Subunit) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Core Binding Factor Alpha 2 Subunit* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Core+Binding+Factor+Alpha+2+Subunit%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Core+Binding+Factor+Alpha+2+Subunit) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * DNA Methylation Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22DNA+Methylation%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=DNA+Methylation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Epigenesis, Genetic* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Epigenesis%2C+Genetic%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Epigenesis%2C+Genetic) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * GATA2 Transcription Factor* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22GATA2+Transcription+Factor%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=GATA2+Transcription+Factor) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * GATA2 Transcription Factor* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22GATA2+Transcription+Factor%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=GATA2+Transcription+Factor) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Hematopoiesis / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hematopoiesis%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hematopoiesis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Leukemia, Myeloid, Acute / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Leukemia%2C+Myeloid%2C+Acute%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Leukemia%2C+Myeloid%2C+Acute) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Leukemia, Myeloid, Acute / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Leukemia%2C+Myeloid%2C+Acute%2Fmetabolism%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Leukemia%2C+Myeloid%2C+Acute) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42801378/) * Myelodysplastic Syndromes / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Myelodysplastic+Syndromes%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Myelodysplastic+Syndromes) * [ Add to Search ](https:
## Related Clinical Research

- [Pope Leo XIV Diagnosed with Lung Adenocarcinoma: Key Insights](https://medichelpline.com/clinical-feed/medical-news-today-0-pope-leo-lung-cancer-diagnosis-what-to-know-about-lung-adenocarcinoma.md)
- [Multimodal AI Models Predict Response to Venetoclax and Azacitidine in Newly Diagnosed AML](https://medichelpline.com/clinical-feed/medrxiv-12-multimodal-artificial-intelligence-fusion-models-to-predict-response-to.md)
- [Cellular Metabolism, Immunity, and Oncogenesis: Drug Discovery Opportunities](https://medichelpline.com/clinical-feed/frontiers-in-immunology-5-editorial-cellular-metabolism-the-immune-system-and-oncogenesis-opportunities.md)
- [Structured aerobic exercise linked to lower cancer recurrence and improved survival](https://medichelpline.com/clinical-feed/medical-news-today-0-aerobic-exercise-could-help-improve-outlook-after-cancer-treatment.md)
- [Sellas Phase 3 REGAL trial for galinpepimut-S faces delays and likely negative outcome in AML](https://medichelpline.com/clinical-feed/stat-news-1-stat-a-sellas-immunotherapy-study-long-delayed-will-end-in-failure.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.